Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling
-
- Rebecca Lamb
- The Breast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Manchester, UK
-
- Gloria Bonuccelli
- The Breast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Manchester, UK
-
- Béla Ozsvári
- The Breast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Manchester, UK
-
- Maria Peiris-Pagès
- The Breast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Manchester, UK
-
- Marco Fiorillo
- The Breast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Manchester, UK
-
- Duncan L. Smith
- The Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK
-
- Generoso Bevilacqua
- FPS - The Pisa Science Foundation, Pisa, Italy
-
- Chiara Maria Mazzanti
- FPS - The Pisa Science Foundation, Pisa, Italy
-
- Liam A. McDonnell
- FPS - The Pisa Science Foundation, Pisa, Italy
-
- Antonio Giuseppe Naccarato
- Department of Pathology, Pisa University Hospital, Pisa, Italy
-
- Maybo Chiu
- The Breast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Manchester, UK
-
- Luke Wynne
- The Breast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Manchester, UK
-
- Ubaldo E. Martinez-Outschoorn
- The Sidney Kimmel Cancer Center, Philadelphia, PA, USA
-
- Federica Sotgia
- The Breast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Manchester, UK
-
- Michael P. Lisanti
- The Breast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Manchester, UK
収録刊行物
-
- Oncotarget
-
Oncotarget 6 (31), 30453-30471, 2015-09-28
Impact Journals, LLC
